Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN.

Slides:



Advertisements
Similar presentations
Dallas 2015 TFQO: Tony Scott #138 EVREV 1: Tony Scott #138 EVREV 2: Anthony Seto # Taskforce: ACS Supplemental Oxygen in ACS 887.
Advertisements

Dallas 2015 TFQO: Allan de Caen COI#38 EVREV 1: Melissa Parker COI#259 EVREV 1: Takanari Ikeyama COI#235 Taskforce: Pediatrics Peds 820 : The use of fluids.
Dallas 2015 TFQO: Myra Wyckoff #COI EVREV 1: Myra Wyckoff #COI EVREV 2: Lindsay Mildenhall #107 Taskforce: NRP NRP: 605 Two thumb verses two finger.
Dallas 2015 TFQO: Marya Strand, MD, MS; COI#222 EVREV 1: Marya Strand, MD, MS; COI#222 EVREV 1: Takahiro Sugiura, MD; COI#224 Taskforce: NLS Umbilical.
Dallas : CPAP and IPPV In spontaneously breathing preterm infants with respiratory distress requiring respiratory support in the delivery room,
Chicago 2014 TFQO: Kee-Chong Ng (#COI = 113) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: EVREVs: de Almeida, Maria Fernanda COI# Trevisanuto, Daniele COI# Taskforce: Neonatal Warming Adjunts #599 Among preterm neonates who.
Chicago 2014 Peter Morley, Eddy Lang E3, GRADE expert Incorporating lower levels of evidence.
Dallas 2015 TFQO: David Stanton COI 328 EVREVs: Volker Wenzel COI 253& Emmanuelle Bourdon COI 333 Taskforce: BLS Passive ventilation techniques.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI 261 EVREV 2: Daniel Pichel COI # 513 Taskforce: ACS ACS 335: Pre-hospital ADP- Receptor.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Charles Deakin COI #221 Taskforce: ALS ALS 714 : Advanced airway placement (SGA.
Peds-818: Pediatric Early Warning Scores
Dallas 2015 TFQO: Vinay Nadkarni MD COI#249 EVREV 1: Graeme Maclaren MBBS COI#98 EVREV 2: Ravi Thiagarajan MBBS, MPH COI#149 Taskforce: PALS Peds 819 :
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Dallas 2015 TFQO: Jeffry Pearlman COI# 187 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP.
Dallas 2015 TFQO: EVREVs: Aaron Donoghue / Jonathan Duff Taskforce: EIT Teaching Compression-Only CPR.
Dallas 2015 TFQO: Masanori Tamura #147 EVREV 1: Masanori Tamura #147 EVREV 2: Susan Niermeyer #252 Delayed Cord Clamping in Preterm Infants Including those.
Therapeutic Hypothermia in Out of Hospital Cardiac Arrest towards
NRP: 862: Use of Feedback CPR Devices for Neonatal Cardiac Arrest NRP: 863: Use of Feedback CPR Devices to detect ROSC for Neonatal Cardiac Arrest TFQO:
Chicago 2014 TFQO: Peter Meaney #COI 149 EVREV 1: Richard Aickin #COI 153 EVREV 1: Peter Meaney #COI 149 Taskforce: Pediatrics Resuscitation fluids (Peds)
Dallas 2015 TFQO: Marilyn Escobedo COI#78 EVREV 1: Marilyn Escobedo COI#78 EVREV 2: Henry Lee COI#135 Taskforce: NRP Babies born to mothers who are hypothermic.
Dallas 2015 TFQO: Robert Greif EVREVs: Jan Breckwoldt, Henrik Fischer Taskforce: Education Implementation and Training (EIT) AED training methods.
Dallas 2015 TFQO: Enrique Udaeta COI# 239 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP 618)
Dallas 2015 TFQO: EVREVs: Guinsburg, Ruth COI# McGowan, Jane COI# Taskforce: Neonatal Apgar Zero #896 In infants ≥36 weeks GA with an Apgar score.
Dallas 2015 TFQO: Name EVREV 1: Jonathan Wyllie COI #282 EVREV 1: Jeff Perlman COI #262 Taskforce: Newborn Temperature Maintenance in the Delivery room.
Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
Chicago 2014 TFQO: Darren Walters COI #317 EVREV 1: Darren Walters COI #317 EVREV 2: Chris Ghaemmaghami COI #60 Taskforce: Acute Coronary Syndrome In STEMI.
Dallas 2015 TFQO: Anne-Marie Guerguerian # 97 EVREV1: Anne-Marie Guerguerian # 97 EVEREV2: Ericka Fink # 83 Taskforce: PEDS Peds 407 : ECMO for pediatric.
Dallas 2015 TFQO: Darren Walters EVREVs: EVREV 1: Darren Walters COI #422 EVREV 2: Chris Ghaemmaghami COI #89 Taskforce: Acute Coronary Syndrome Fibrinolytic.
First Aid 801: Stroke Recognition
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 4 (maximum) using standard.
Dallas 2015 TFQO: David Boyle COI #26 EVREV 1: David Boyle #COI#26 EVREV 1: Jane McGowan #370 Taskforce: Neonatal Ventilation Strategies in the DR (NRP.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 6 (maximum) using standard.
Dallas 2015 TFQO: Michael Sayre COI #400 EVREV 1: Mohamud Daya COI #327 EVREV 2: Jan-Thorsten Gräsner COI #230 Taskforce: BLS BLS 363: CPR Prior to Defibrillation.
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
UT Southwestern Medical Center at Dallas
Dallas 2015 TFQO: Kee-Chong Ng (#COI = 170) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Chicago 2014 Pediatric RRT/MET Teams #397 TFQO: Dianne Atkins COI #7 EVREV 1: Dianne Atkins EVREV 2: Kee Chong Ng COI #113 Taskforce: Peds.
TFQO: Jasmeet Soar #COI 272 EVREV 1: Jasmeet Soar #COI 272 EVREV 2: Michael Donnino #COI 222 Taskforce: ALS ALS 448 OXYGEN DOSE AFTER ROSC IN ADULTS 3.
Dallas 2015 TFQO: Maaret Castrén #320 EVREV 1: Christian Vaillancourt #416 EVREV 2: Michael Sayre #400 Taskforce: BLS BLS 359: Dispatcher Instructions.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREVs: Jan Jensen COI #115 Richard N. Bradley COI #151 Taskforce: First Aid 769: Hemostatic Dressings.
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Michael W. Donnino COI# EVREVs: Katherine M. Berg COI# Lars W. Andersen COI# Taskforce: ALS Ultrasound During CPR.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREV: Michael Reilly COI #193 Taskforce: First Aid First Aid 768: Use of Tourniquet.
Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Jan-Thorsten Graesner COI #150 Taskforce: ALS ALS 783 : Advanced versus basic.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
Dallas 2015 TFQO: Hiroshi Nonogi #254 EVREVs: Hiroshi Nonogi #254 Tony Scott #138 Taskforce: ACS Fibrinolytic and immediate PCI for STEMI 882.
LINC Trial LUCAS in cardiac arrest trial. What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS.
Dallas 2015 TFQO: S. Velaphi EVREV 1: N. Singhal COI #213 EVREV 2: S. Velaphi COI #242 EVREV 3: H. Ersdal – COI # 76 Taskforce: NLS Prognosis: In newborn.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
A pilot randomized controlled trial Registry #: NCT
Abstract Cardiopulmonary Resuscitation with Rescue Breathing Is Superior to Hands-Only Cardiopulmonary Resuscitation for Children and Infants: Results.
Top 5 papers of Prehospital care Recommended by Torpong.
Dallas 2015 TFQO: Michael Donnino #222 EVREV 1: Joshua Reynolds COI #265 EVREV 2: Katherine Berg COI #10 Taskforce: ALS ALS 790 : Induced Hypothermia.
Uncontrolled organ donation after circulatory death protocols in out-of-hospital cardiac arrests. A potential solution to organ shortage? Alexandre Garioud1*,
Resuscitation in special circumstances workshop Asthma
SSAI Malmö MD, PhD, FCICM, EDIC Markus Skrifvars
Extracorporeal Cardiopulmonary Resuscitation (ECPR) in Adults:
Overview of the GRADE approach – selected slides
What is LINC? A multicenter, randomized, controlled trial
Presentation transcript:

Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN ADULTS 30 January 2015

Dallas 2015 COI Disclosure [relevant to this PICO] Jasmeet Soar #COI 409 Commercial/industry None Potential intellectual conflicts None Anthony Lagina COI# 357 Commercial/industry None Potential intellectual conflicts None

Dallas CoS

Dallas Treatment Recommendation There is insufficient evidence to support or refute the use of a titrated oxygen concentration or constant 21% oxygen (room air) when compared with 100% oxygen during adult cardiac arrest. In the absence of any other data there is no reason to change the current treatment algorithm, which includes use of 100% oxygen during adult cardiac arrest.

Dallas 2015 C2015 PICO P - In adults with cardiac arrest in any setting I – does giving a maximal oxygen concentration (100% inspired) C – no supplemental oxygen or a reduced oxygen concentration O - change Survival with favorable neurological/functional outcome at discharge, 30 days, 60 days, 180 days AND/OR 1 year (9 - critical outcome), Survival at discharge, 30 days, 60 days, 180 days AND/OR 1 year (7/8 - critical outcome)? ROSC (5 - important)?

Dallas Proposed Treatment Recommendations We suggest the use of the maximal feasible inspired oxygen concentration during CPR (weak recommendation, very low quality evidence). In making this recommendation we have considered the limited available evidence, the need to correct tissue hypoxia during CPR, and see no reason to change the current treatment recommendation, which includes use of 100% inspired oxygen during adult cardiac arrest.

Dallas 2015 Inclusion/Exclusion & Articles Found [25 Sep 2014] Inclusions - Adults and children, all languages Exclude - Letters, editorials, comments and case reports, newborn and neonatal studies 1047 papers after excluding duplicates 1026 excluded first pass 20 excluded second pass from reading abstracts 1 non RCT identified

Dallas 2015 Risk of Bias in studies StudyYear Total Patients Populatio n Industry Funding Eligibility Criteria Exposure/Outcom e Confounding Follow up Spindelboeck OHCA non- traumatic, and PaO2 measured No High Low

Dallas 2015 Key Study Spindelboeck et al. Resuscitation Jun;84(6): P:145 adults OHCA, single EMS receiving 100% inspired oxygen during CPR I: High PaO 2 during CPR C: Low PaO 2 during CPR O: any ROSC, CPC 1 or 2 at discharge

Dallas 2015 Low PaO 2 = 0 – 60 mmHg = 0 – 8 kPa Intermediate PaO 2 = 61 – 300 mmHg = 8.1 – 40 kPa High PaO 2 = > 300 mmHg = > 40 kPa

Dallas 2015 Spindelboeck et al. Resuscitation Jun;84(6):770-5.

Dallas 2015

Survival with Favorable neurological/functional outcome at discharge/30 days, [CPC 1 or 2 at discharge or day 28 ]

Dallas 2015 Survival with Favorable neurological/functional outcome at discharge/30 days, [CPC 1 or 2 at discharge or day 28 ]

Dallas 2015 Intermediate PaO 2 vs. Low PaO 2 11/83 vs. 1/32 RR 4.2 (95% CI 0.57 – 31.52) P = 0.16 High PaO 2 vs. Low PaO 2 7/30 vs. 1/32 RR 7.45 (95% CI 0.98 – 57.15) P = High PaO 2 vs. Intermediate PaO 2 7/30 vs. 11/83 RR 1.76 (95% CI 0.75 – 4.12) P = 0.19

Dallas Only patients with arterial blood gas during CPR included - 860/1005 excluded as no blood gas – very serious bias 2.Study does not look at inspired oxygen - patient's PaO2 during CPR – very serious indirectness 3.Underpowered - small numbers with endpoints, wide CI – serious imprecision 4.PaO 2 values may be low due to underlying disease, all patients received 100% inspired oxygen via tracheal tube.

Dallas 2015 ROSC

Dallas 2015 ROSC

Dallas 2015 Intermediate PaO 2 vs. Low PaO 2 47/83 vs. 7/32 RR 2.59 (95% CI 1.31 – 5.12) P = High PaO 2 vs. Low PaO 2 25/30 vs. 7/32 RR 3.81 (95% CI 1.94 – 7.48) P = High PaO 2 vs. Intermediate PaO 2 25/30 vs. 47/83 RR 1.47 (95% CI 1.15 – 1.88) P = 0.002

Dallas 2015 Proposed Consensus on Science There are no adult human studies that directly compare maximal inspired oxygen with any other inspired oxygen concentration. For the critical outcome of survival to hospital discharge with favourable neurological outcome (CPC 1 or 2) we identified very low quality evidence (downgraded for very serious risk of bias and very serious indirectness, and serious imprecision) from 1 observational study [Spindelboeck ] enrolling 145 OHCA patients who had a PaO 2 measured during CPR that showed no difference between an intermediate PaO 2 and low PaO 2 [11/83 vs. 1/32, RR 4.2 (95 CI 0.57 – 31.52) P = 0.16], or between a high PaO 2 and low PaO 2 [7/30 vs. 1/32 RR 7.45 (95 CI 0.98 – 57.15) P = 0.053].

Dallas 2015 For the important outcome of ROSC we identified very low quality evidence (downgraded for very serious risk of bias and very serious indirectness, and serious imprecision) from 1 observational study [Spindelboeck ] enrolling 145 OHCA patients who had a PaO 2 measured during CPR that showed improved ROSC in those with a higher PaO 2 ; [Intermediate PaO 2 vs. Low PaO 2 47/83 vs. 7/32 RR 2.59 (95% CI 1.31 – 5.12) P = 0.006], [High PaO 2 vs. Low PaO 2 25/30 vs. 7/32 RR 3.81 (95% CI 1.94 – 7.48) P = ], [High PaO 2 vs. Intermediate PaO 2 25/30 vs. 47/83, RR 1.47 (95% CI 1.15 – 1.88) P=0.002]. Proposed Consensus on Science

Dallas 2015 In the single identified study [Spindelboeck ] all patients had tracheal intubation and received 100% inspired oxygen during CPR. The worse outcomes associated with a low PaO 2 during CPR could be an indication of illness severity. Proposed Consensus on Science

Dallas Proposed Treatment Recommendations We suggest the use of the maximal feasible inspired oxygen concentration during CPR (weak recommendation, very low quality evidence). In making this recommendation we have considered the limited available evidence, the need to correct tissue hypoxia during CPR, and see no reason to change the current treatment recommendation, which includes use of 100% inspired oxygen during adult cardiac arrest.

Dallas 2015 Knowledge Gaps We do not know the optimal arterial or tissue oxygen targets during CPR. We do not have any way of reliably monitoring oxygen targets during CPR. We do not know the feasibility of controlling inspired oxygen concentration during CPR. Prospective clinical trials may be warranted to explore different inspired oxygen concentrations (including air) during CPR. The role and feasibility of alternatives to oxygen/air mixtures during CPR.

Dallas 2015 Next Steps This slide will be completed during Task Force Discussion (not EvRev) and should include: Consideration of interim statement Person responsible Due date